Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Helge Müller

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 19, 2025
Biventricular vs. right ventricular pacing devices in patients anticipated to require frequent ventricular pacing (BioPace)Reinhard C Funck, Hans-Helge Müller, Maurizio Lunati, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2012
Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trialMatthias Kroiss, Marcus Quinkler, Sarah Johanssen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 17, 2024
Connectivity based on glucose dynamics reveals exaggerated sensorimotor network coupling on subject-level in Parkinson's diseaseMarina C Ruppert-Junck, Vanessa Heinecke, Damiano Librizzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study GroupAnja Rinke, Hans-Helge Müller, Carmen Schade-Brittinger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 13, 2023
Reduced Gastric Contraction in Rapid-Eye-Movement Sleep Behavior Disorder and De Novo Parkinson's DiseaseWolfgang H Oertel, Esther Paule, Theresa Hasemann, et al.
NEJM Evidence|February 6, 2024
Transdermal Nicotine Treatment and Progression of Early Parkinson's DiseaseWolfgang H Oertel, Hans-Helge Müller, Marcus M Unger, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2005
Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trialRudolf Arnold, Anja Rinke, Klaus-Jochen Klose, et al.
The British Journal of Ophthalmology|November 2, 2017
Calculating the individual probability of successful ocriplasmin treatment in eyes with VMT syndrome: a multivariable prediction model from the EXPORT studyChristoph Paul, Christine Heun, Hans-Helge Müller, et al.
BMC Neurology|January 11, 2017
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trialKatharina Feil, Christine Adrion, Julian Teufel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancerAndreas du Bois, Jørn Herrstedt, Anne-Claire Hardy-Bessard, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 19, 2025
Biventricular vs. right ventricular pacing devices in patients anticipated to require frequent ventricular pacing (BioPace)Reinhard C Funck, Hans-Helge Müller, Maurizio Lunati, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2012
Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trialMatthias Kroiss, Marcus Quinkler, Sarah Johanssen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 17, 2024
Connectivity based on glucose dynamics reveals exaggerated sensorimotor network coupling on subject-level in Parkinson's diseaseMarina C Ruppert-Junck, Vanessa Heinecke, Damiano Librizzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study GroupAnja Rinke, Hans-Helge Müller, Carmen Schade-Brittinger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 13, 2023
Reduced Gastric Contraction in Rapid-Eye-Movement Sleep Behavior Disorder and De Novo Parkinson's DiseaseWolfgang H Oertel, Esther Paule, Theresa Hasemann, et al.
NEJM Evidence|February 6, 2024
Transdermal Nicotine Treatment and Progression of Early Parkinson's DiseaseWolfgang H Oertel, Hans-Helge Müller, Marcus M Unger, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2005
Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trialRudolf Arnold, Anja Rinke, Klaus-Jochen Klose, et al.
The British Journal of Ophthalmology|November 2, 2017
Calculating the individual probability of successful ocriplasmin treatment in eyes with VMT syndrome: a multivariable prediction model from the EXPORT studyChristoph Paul, Christine Heun, Hans-Helge Müller, et al.
BMC Neurology|January 11, 2017
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trialKatharina Feil, Christine Adrion, Julian Teufel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancerAndreas du Bois, Jørn Herrstedt, Anne-Claire Hardy-Bessard, et al.
Pageof 8